Clinical trial
PRecisiOn Medicine In StrokE Study on the Evolution of Plasma Brain-Derived Tau in 100 Patients With Acute Ischemic Stroke
NCT06121336 is registered in ClinicalTrials.gov with Ludwig-Maximilians - University of Munich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PRecisiOn Medicine In StrokE Study on the Evolution of Plasma Brain-Derived Tau in 100 Patients With Acute Ischemic Stroke
- Lead sponsor
- Ludwig-Maximilians - University of Munich
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 1, 2023
- Completion date
- March 31, 2027
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brain diseases, brain ischemia, central nervous system diseases, cerebrovascular disorders, nervous system diseases, stroke, stroke, acute, stroke, ischemic